[HTML][HTML] Individualized clinical management of patients at risk for Alzheimer's dementia
Abstract Introduction Multidomain intervention for Alzheimer's disease (AD) risk reduction is
an emerging therapeutic paradigm. Methods Patients were prescribed individually tailored
interventions (education/pharmacologic/nonpharmacologic) and rated on compliance.
Normal cognition/subjective cognitive decline/preclinical AD was classified as Prevention.
Mild cognitive impairment due to AD/mild-AD was classified as Early Treatment. Change
from baseline to 18 months on the modified Alzheimer's Prevention Cognitive Composite …
an emerging therapeutic paradigm. Methods Patients were prescribed individually tailored
interventions (education/pharmacologic/nonpharmacologic) and rated on compliance.
Normal cognition/subjective cognitive decline/preclinical AD was classified as Prevention.
Mild cognitive impairment due to AD/mild-AD was classified as Early Treatment. Change
from baseline to 18 months on the modified Alzheimer's Prevention Cognitive Composite …